Skip to main content
. 2020 Apr 29;42(1):405–412. doi: 10.1080/0886022X.2020.1756846

Figure 5.

Figure 5.

Comparison of plasma PCSK9 levels in patients with MCD and MN The plasma levels of PCSK9 in the MCD and MN groups were 320.51 ± 131.15 ng/ml 341.55 ± 100.54. ngmL, respectively, (p = 0.408). MCD, minimal change disease; MN, membranous nephropathy.